These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19080698)

  • 21. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
    Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS
    Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of Helicobacter pylori in follicular and nonfollicular gastritis.
    Mehmet S; Ozdal E; Kamil O; Beşir K; Huseyin D; Nihat A; Cigdem EY; Nusret E
    Hepatogastroenterology; 2009; 56(91-92):930-4. PubMed ID: 19621732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Helicobacter pylori infection 2011.
    O'Connor A; Gisbert JP; McNamara D; O'Morain C
    Helicobacter; 2011 Sep; 16 Suppl 1():53-8. PubMed ID: 21896086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy.
    Vaira D; Ricci C; Lanzini A; Perna F; Romano A; Corinaldesi R
    Dig Dis; 2007; 25(3):203-5. PubMed ID: 17827940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.
    Peedikayil MC; Alsohaibani FI; Alkhenizan AH
    PLoS One; 2014; 9(1):e85620. PubMed ID: 24465624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure.
    Page RL; Ferguson D; Cantu M
    Cardiology; 2008; 110(2):112-5. PubMed ID: 17971660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
    Severi C; Abdullahi M; Tari R; Vannella L; Marcheggiano A; Capoccia D; Leonetti F; Osborn J; Annibale B
    Dig Liver Dis; 2009 Aug; 41(8):555-8. PubMed ID: 19179127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
    Sánchez-Delgado J; Calvet X; Bujanda L; Gisbert JP; Titó L; Castro M
    Am J Gastroenterol; 2008 Sep; 103(9):2220-3. PubMed ID: 18564109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children.
    Horvath A; Dziechciarz P; Szajewska H
    Aliment Pharmacol Ther; 2012 Sep; 36(6):534-41. PubMed ID: 22827718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis.
    Xiao SP; Gu M; Zhang GX
    Scand J Gastroenterol; 2014 May; 49(5):528-38. PubMed ID: 24611790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
    Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
    Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of faropenem in eradication therapy of Helicobacter pylori.
    Ogura K; Mitsuno Y; Maeda S; Hirata Y; Yanai A; Shibata W; Ohmae T; Yoshida H; Kawabe T; Omata M
    Helicobacter; 2007 Dec; 12(6):618-22. PubMed ID: 18001403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: Helicobacter pylori eradication treatment efficacy in children.
    Khurana R; Fischbach L; Chiba N; VAN Zanten SV; Sherman PM; George BA; Goodman KJ; Gold BD
    Aliment Pharmacol Ther; 2007 Mar; 25(5):523-36. PubMed ID: 17305754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
    Sánchez-Delgado J
    Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
    [No Abstract]   [Full Text] [Related]  

  • 37. Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication.
    Gisbert JP; Bermejo MF; Infante JM; Gallardo BP; Bermejo AB; Rodríguez JM; Andrés PR; García GG
    J Clin Gastroenterol; 2009 Apr; 43(4):384-5. PubMed ID: 19020466
    [No Abstract]   [Full Text] [Related]  

  • 38. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.
    Tong JL; Ran ZH; Shen J; Zhang CX; Xiao SD
    Aliment Pharmacol Ther; 2007 Jan; 25(2):155-68. PubMed ID: 17229240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.